<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine Dosing for Older Adults: Adjusted Protocols for 50+</title>
  <meta name="description" content="Evidence-based creatine dosing protocols adjusted for adults over 50. Covers age-related considerations, lean mass preservation, cognitive benefits, and...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatinepedia.com/dosing/creatine-for-older-adults-dosing">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatinepedia.com/dosing/creatine-for-older-adults-dosing">
  <meta property="og:title" content="Creatine Dosing for Older Adults: Adjusted Protocols for 50+">
  <meta property="og:description" content="Evidence-based creatine dosing protocols adjusted for adults over 50. Covers age-related considerations, lean mass preservation, cognitive benefits, and...">
  <meta property="og:site_name" content="Creatine Research">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine Dosing for Older Adults: Adjusted Protocols for 50+">
  <meta name="twitter:description" content="Evidence-based creatine dosing protocols adjusted for adults over 50. Covers age-related considerations, lean mass preservation, cognitive benefits, and...">
  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "Why Older Adults Require Different Creatine Protocols?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Aging imposes several physiological changes that alter how the body synthesizes, stores, and uses creatine. After age 50, skeletal muscle mass declines at roughly 1&ndash;2% per year, a process termed sarcopenia. This loss is not merely cosmetic. It reduces functional capacity, increases fall risk, and correlates with increased all-cause mortality. Creatine supplementation represents one of the few nutritional interventions with strong evidence for attenuating age-related muscle decline, but dosing protocols developed for 20-year-old athletes do not automatically transfer to a 65-year-old beginning a resistance training program."
      }
    },
    {
      "@type": "Question",
      "name": "What are the age-related considerations in creatine metabolism?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Several factors specific to aging influence how creatine should be dosed:"
      }
    },
    {
      "@type": "Question",
      "name": "What is the recommended adjusted loading protocol for adults 50+?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The standard loading protocol (4 x 5 g per day for 5&ndash;7 days) can be modified for older adults:"
      }
    },
    {
      "@type": "Question",
      "name": "What is the lean mass preservation?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The most extensively studied benefit of creatine in older adults is lean mass preservation when combined with resistance training. Chilibeck et al. (2017) conducted a meta-analysis of 22 studies examining creatine supplementation in adults over 50 engaged in resistance training. The pooled effect was clear: creatine plus resistance training produced significantly greater increases in lean tissue mass compared to resistance training with placebo."
      }
    },
    {
      "@type": "Question",
      "name": "What is the recommended cognitive dosing?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Creatine is not only stored in muscle. The brain maintains its own creatine pool and relies on the phosphocreatine system for energy buffering. Age-related cognitive decline correlates with reductions in brain creatine levels, and supplementation may offer neuroprotective benefits."
      }
    }
  ]
}
  </script>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">Research</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">Research Updates</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">Evidence-Based Research</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">Every article cites peer-reviewed studies. No marketing hype. Just what the science shows.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Complete Research Guide
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get Research Updates</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/dosing" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Dosing Protocols</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <div class="prose">

      <nav aria-label="Breadcrumb" class="text-sm text-zinc-500 mb-8">
        <a href="/" class="hover:text-sky-400">Home</a>
        <span class="mx-2">/</span>
        <a href="/dosing/" class="hover:text-sky-400">Dosing Protocols</a>
        <span class="mx-2">/</span>
        <span class="text-zinc-300">Older Adults Dosing</span>
      </nav>

      <header class="mb-12">
        <h1 class="font-serif text-4xl lg:text-5xl text-zinc-100 mb-4">Creatine Dosing for Older Adults: Adjusted Protocols for 50+</h1>
        <p class="text-lg text-zinc-400">Age-related muscle loss, cognitive decline, and reduced creatine synthesis demand adjusted supplementation strategies. Here is what the clinical data supports for adults over 50.</p>
        <div class="flex items-center gap-4 mt-4 text-sm text-zinc-500">
          <time datetime="2026-01-28">January 28, 2026</time>
          <span>|</span>
          <span>9 min read</span>
        </div>
      </header>

      <h2>Why Older Adults Require Different Creatine Protocols</h2>

      <p>Aging imposes several physiological changes that alter how the body synthesizes, stores, and uses creatine. After age 50, skeletal muscle mass declines at roughly 1&ndash;2% per year, a process termed sarcopenia. This loss is not merely cosmetic. It reduces functional capacity, increases fall risk, and correlates with increased all-cause mortality. Creatine supplementation represents one of the few nutritional interventions with strong evidence for attenuating age-related muscle decline, but dosing protocols developed for 20-year-old athletes do not automatically transfer to a 65-year-old beginning a resistance training program.</p>

      <p>Endogenous creatine production decreases with age. The liver and kidneys synthesize roughly 1 g of creatine daily, but this output declines as organ function slows. Dietary intake also tends to decrease as older adults consume less meat and fish. The result is lower baseline intramuscular creatine stores, which means older adults may actually stand to benefit more from supplementation than younger populations&mdash;if the dosing is appropriate.</p>

      <h2>Age-Related Considerations in Creatine Metabolism</h2>

      <p>Several factors specific to aging influence how creatine should be dosed:</p>

      <h3>Reduced Muscle Mass and Total Body Water</h3>

      <p>Creatine is stored almost exclusively in skeletal muscle. An older adult with significantly less muscle mass than a younger counterpart has a smaller creatine storage pool. Standard loading protocols (20 g/day) were derived from studies on young, muscular subjects. For an older adult weighing 70 kg with reduced lean mass, the effective loading dose is lower, and the saturation threshold is reached sooner. Excess creatine beyond storage capacity is simply excreted, increasing the workload on aging kidneys without providing additional benefit.</p>

      <h3>Renal Function Decline</h3>

      <p>Glomerular filtration rate (GFR) decreases approximately 1 mL/min per year after age 40. While creatine supplementation at standard doses has not been shown to impair renal function in healthy adults (Gualano et al., 2012), there is reason to exercise caution with aggressive loading protocols in older populations. Adjusted protocols reduce renal burden while still achieving muscle saturation.</p>

      <h3>Altered Creatine Transporter Expression</h3>

      <p>Research suggests that creatine transporter (CrT) expression may decline with age, meaning muscle cells are less efficient at absorbing creatine from the blood. This does not eliminate the benefit of supplementation, but it may lengthen the time needed to reach saturation. Candow et al. (2019) found that older adults still achieved significant intramuscular creatine increases, but the kinetics differed from younger cohorts.</p>

      <h2>Adjusted Loading Protocol for Adults 50+</h2>

      <p>The standard loading protocol (4 x 5 g per day for 5&ndash;7 days) can be modified for older adults:</p>

      <table>
        <thead>
          <tr>
            <th>Phase</th>
            <th>Standard Protocol (18-40y)</th>
            <th>Adjusted Protocol (50+)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Loading</td>
            <td>20 g/day for 5-7 days</td>
            <td>10-14 g/day for 7-10 days</td>
          </tr>
          <tr>
            <td>Maintenance</td>
            <td>3-5 g/day</td>
            <td>3-5 g/day (0.07 g/kg body weight)</td>
          </tr>
          <tr>
            <td>Alternative (no loading)</td>
            <td>3-5 g/day for 28 days</td>
            <td>3-5 g/day for 28-30 days</td>
          </tr>
        </tbody>
      </table>

      <p>The reduced loading dose (10&ndash;14 g/day split into 2&ndash;3 doses) accounts for smaller lean mass and reduced creatine transporter capacity. It minimizes gastrointestinal discomfort, which older adults report more frequently at high doses, while still achieving saturation within 7&ndash;10 days. Many clinicians now recommend skipping the loading phase entirely for older adults and using the daily 3&ndash;5 g maintenance approach from the start, which reaches equivalent saturation by day 28.</p>

      <h2>Lean Mass Preservation: The Primary Outcome</h2>

      <p>The most extensively studied benefit of creatine in older adults is lean mass preservation when combined with resistance training. Chilibeck et al. (2017) conducted a meta-analysis of 22 studies examining creatine supplementation in adults over 50 engaged in resistance training. The pooled effect was clear: creatine plus resistance training produced significantly greater increases in lean tissue mass compared to resistance training with placebo.</p>

      <p>The effect sizes are clinically meaningful. Candow et al. (2019) demonstrated that 12 weeks of creatine supplementation (0.1 g/kg/day) combined with resistance training in older adults (50&ndash;71 years) increased lean mass by approximately 1.2 kg more than resistance training alone. For a population losing 0.5&ndash;1 kg of muscle per year, this reversal is significant.</p>

      <p>Chilibeck et al. (2015) conducted a 12-month randomized, double-blind, placebo-controlled trial in older adults (age 59.4 +/- 8.8 years) and found that creatine supplementation combined with resistance exercise training improved several measures of muscular strength and body composition. Lean mass gains were maintained for the duration of supplementation.</p>

      <h3>Dosing for Lean Mass Outcomes</h3>

      <p>The research supports a body-weight-adjusted maintenance dose of 0.07&ndash;0.10 g/kg/day for lean mass benefits. For a 75 kg older adult, this translates to 5.3&ndash;7.5 g/day. Most practical recommendations settle at 5 g/day for simplicity, which falls within the effective range for adults of average body weight.</p>

      <h2>Cognitive Dosing: The Emerging Application</h2>

      <p>Creatine is not only stored in muscle. The brain maintains its own creatine pool and relies on the phosphocreatine system for energy buffering. Age-related cognitive decline correlates with reductions in brain creatine levels, and supplementation may offer neuroprotective benefits.</p>

      <p>Rae et al. (2003) demonstrated that creatine supplementation (5 g/day for six weeks) improved working memory and processing speed in healthy adults. McMorris et al. (2007) found that creatine supplementation (20 g/day for 7 days) improved cognitive performance in older adults (68&ndash;85 years), particularly under conditions of stress and sleep deprivation.</p>

      <p>The optimal dose for cognitive outcomes in older adults is not yet fully established. Brain creatine uptake is slower than muscle uptake due to the blood-brain barrier, which has limited creatine transport capacity. Current evidence suggests that daily doses of 5&ndash;8 g sustained over weeks to months are needed to meaningfully increase brain creatine concentrations. Some researchers have proposed that older adults may benefit from a higher daily dose (8 g/day) specifically targeting cognitive outcomes, though this remains under investigation.</p>

      <h3>Practical Cognitive Protocol</h3>

      <p>For older adults interested in cognitive benefits, the practical recommendation is 5 g/day of creatine monohydrate taken consistently. The brain creatine pool takes longer to saturate than muscle (potentially 8&ndash;12 weeks), so patience is required. There is no evidence that loading phases accelerate brain creatine uptake, making the standard daily dose the most practical approach.</p>

      <h2>Combined With Resistance Training: The Synergistic Protocol</h2>

      <p>Creatine without exercise still confers some benefit to older adults, but the combination with resistance training produces substantially greater effects. The interaction is not additive but synergistic&mdash;creatine enhances the quality of resistance training sessions, which in turn enhances the adaptive stimulus for muscle growth.</p>

      <p>Candow et al. (2008) examined creatine timing in older adults performing resistance training 3 days per week. Participants receiving creatine (0.1 g/kg) on training days and rest days alike experienced greater strength gains than those receiving placebo. The effect was consistent across upper and lower body exercises.</p>

      <p>The optimal training-creatine protocol for older adults:</p>

      <ol>
        <li>Resistance training: 2&ndash;3 sessions per week, targeting all major muscle groups</li>
        <li>Creatine dose: 5 g/day (or 0.07&ndash;0.10 g/kg/day for body weight adjustment)</li>
        <li>Timing: Take creatine with a meal containing carbohydrate and protein to enhance uptake via insulin-mediated creatine transporter activation</li>
        <li>Duration: Continuous supplementation; no cycling required</li>
        <li>Training-day dose: Can be taken before or after training; post-exercise may offer slight advantages due to increased muscle blood flow and creatine transporter activity</li>
      </ol>

      <h2>Safety Considerations for Older Adults</h2>

      <p>The safety profile of creatine in older populations has been well-documented. Gualano et al. (2012) conducted a comprehensive review and found no adverse effects on renal function, hepatic function, or cardiovascular markers in older adults supplementing with creatine at recommended doses. Candow et al. (2019) confirmed these findings in a population aged 50&ndash;71 over 12 weeks.</p>

      <p>Specific safety notes for older adults:</p>

      <ul>
        <li><strong>Hydration:</strong> Creatine increases intracellular water retention. Older adults should maintain adequate fluid intake (at least 2&ndash;2.5 L/day) to support this process and maintain renal function.</li>
        <li><strong>Kidney disease:</strong> Those with pre-existing chronic kidney disease (CKD) should consult a nephrologist before supplementing. Standard doses have not been shown to cause kidney damage in healthy individuals, but compromised renal function warrants medical supervision.</li>
        <li><strong>Medication interactions:</strong> Creatine does not have well-documented drug interactions, but older adults taking nephrotoxic medications or diuretics should discuss supplementation with their physician.</li>
        <li><strong>Weight gain:</strong> Initial weight gain of 1&ndash;2 kg from water retention is normal and expected. This is not fat gain and should not be misinterpreted as an adverse effect.</li>
        <li><strong>GI tolerance:</strong> Lower divided doses (e.g., 2.5 g twice daily rather than 5 g at once) reduce gastrointestinal discomfort, which older adults may experience more readily.</li>
      </ul>

      <h2>Practical Summary</h2>

      <p>Creatine is one of the most well-supported supplements for older adults, with strong evidence for lean mass preservation, strength gains, and emerging evidence for cognitive protection. The adjusted protocol is straightforward:</p>

      <ul>
        <li>Use creatine monohydrate (the most studied form)</li>
        <li>Start at 3&ndash;5 g per day without a loading phase, or use a reduced loading dose of 10&ndash;14 g/day for 7&ndash;10 days</li>
        <li>Maintain at 5 g/day (or 0.07&ndash;0.10 g/kg for body weight precision)</li>
        <li>Take with meals containing protein and carbohydrate</li>
        <li>Combine with resistance training 2&ndash;3 days per week for maximal benefit</li>
        <li>Supplement continuously; cycling is unnecessary</li>
        <li>Allow 4&ndash;12 weeks to observe measurable effects on strength and lean mass</li>
      </ul>

      <p>The research is unambiguous on this point: creatine supplementation combined with resistance training is one of the most effective, safe, and affordable strategies available to combat age-related muscle and functional decline.</p>

      <h2>Bibliography</h2>

      <ol class="ref-list">
        <li>Candow DG, Forbes SC, Chilibeck PD, Cornish SM, Antonio J, Kreider RB. Effectiveness of creatine supplementation on aging muscle and bone: Focus on falls prevention and inflammation. <em>J Clin Med</em>. 2019;8(4):488. doi:10.3390/jcm8040488</li>
        <li>Chilibeck PD, Kaviani M, Candow DG, Zello GA. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. <em>Open Access J Sports Med</em>. 2017;8:213-226. doi:10.2147/OAJSM.S148650</li>
        <li>Chilibeck PD, Candow DG, Landeryou T, Kaviani M, Paus-Jenssen L. Effects of creatine and resistance training on bone health in postmenopausal women. <em>Med Sci Sports Exerc</em>. 2015;47(8):1587-1595. doi:10.1249/MSS.0000000000000571</li>
        <li>Candow DG, Chilibeck PD, Burke DG, Mueller KD, Lewis JD. Effect of different frequencies of creatine supplementation on muscle size and strength in young adults. <em>J Strength Cond Res</em>. 2011;25(7):1831-1838. doi:10.1519/JSC.0b013e3181e7419a</li>
        <li>Gualano B, Rawson ES, Candow DG, Chilibeck PD. Creatine supplementation in the aging population: effects on skeletal muscle, bone and brain. <em>Amino Acids</em>. 2016;48(8):1793-1805. doi:10.1007/s00726-016-2239-7</li>
        <li>Gualano B, de Salles Painelli V, Roschel H, et al. Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. <em>Eur J Appl Physiol</em>. 2011;111(5):749-756. doi:10.1007/s00421-010-1676-3</li>
        <li>Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. <em>Proc R Soc Lond B Biol Sci</em>. 2003;270(1529):2147-2150. doi:10.1098/rspb.2003.2492</li>
        <li>McMorris T, Mielcarz G, Harris RC, Swain JP, Howard A. Creatine supplementation and cognitive performance in elderly individuals. <em>Neuropsychol Dev Cogn B Aging Neuropsychol Cogn</em>. 2007;14(5):517-528. doi:10.1080/13825580600788100</li>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>J Int Soc Sports Nutr</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z</li>
      </ol>

    </div>
      
      
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>Why Older Adults Require Different Creatine Protocols?</h3>
          <p>Aging imposes several physiological changes that alter how the body synthesizes, stores, and uses creatine. After age 50, skeletal muscle mass declines at roughly 1&ndash;2% per year, a process termed sarcopenia. This loss is not merely cosmetic. It reduces functional capacity, increases fall risk, and correlates with increased all-cause mortality. Creatine supplementation represents one of the few nutritional interventions with strong evidence for attenuating age-related muscle decline, but dosing protocols developed for 20-year-old athletes do not automatically transfer to a 65-year-old beginning a resistance training program.</p>
        </div>
        <div class="faq-item">
          <h3>What are the age-related considerations in creatine metabolism?</h3>
          <p>Several factors specific to aging influence how creatine should be dosed:</p>
        </div>
        <div class="faq-item">
          <h3>What is the recommended adjusted loading protocol for adults 50+?</h3>
          <p>The standard loading protocol (4 x 5 g per day for 5&ndash;7 days) can be modified for older adults:</p>
        </div>
        <div class="faq-item">
          <h3>What is the lean mass preservation?</h3>
          <p>The most extensively studied benefit of creatine in older adults is lean mass preservation when combined with resistance training. Chilibeck et al. (2017) conducted a meta-analysis of 22 studies examining creatine supplementation in adults over 50 engaged in resistance training. The pooled effect was clear: creatine plus resistance training produced significantly greater increases in lean tissue mass compared to resistance training with placebo.</p>
        </div>
        <div class="faq-item">
          <h3>What is the recommended cognitive dosing?</h3>
          <p>Creatine is not only stored in muscle. The brain maintains its own creatine pool and relies on the phosphocreatine system for energy buffering. Age-related cognitive decline correlates with reductions in brain creatine levels, and supplementation may offer neuroprotective benefits.</p>
        </div>
      </section>
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current on Creatine Research</h3>
        <p>Get evidence-based updates when new studies are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get Research Updates</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/dosing/creatine-dosing-protocols-summary">Complete Dosing Guide: Dosing Protocols</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/dosing" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Dosing Protocols</a>
        </div>
        <a href="/dosing" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">Research Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New studies, mechanism breakdowns, and dosing insights — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatine Research</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">Evidence-based creatine research. Every claim cited. No marketing hype.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">Research Updates</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatine Research. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>